Press release
-
Press Release
Squirro Drives Frictionless Enterprise AI Real-World Adoption with Latest Platform Release
Supercharges Chat and Multimodal Reasoning Capabilities ZURICH, Dec. 15, 2025 /PRNewswire/ — Squirro, a global leader in enterprise-grade Generative AI and…
Read More » -
Press Release
OLLOBOT to Make Its Debut at CES 2026
LAS VEGAS, Dec. 15, 2025 /PRNewswire/ — OLLOBOT, a brand focused on fusing advanced technology with emotional companionship, will make…
Read More » -
Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ — Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines…
Read More » -
Press Release
Macao and Zhuhai Co-Host Tech Expo, Highlighting China’s Smart Manufacturing Capabilities for Global Markets
MACAO, Dec. 12, 2025 /PRNewswire/ — The Global Artificial Intelligence Machines and Electronics Expo 2025 opened on December 4. Held…
Read More » -
Press Release
AIE Expo Aims to Build Global Hub for Tech Dialogue
MACAO, Dec. 12, 2025 /PRNewswire/ — This release is based on a report from Xinhua News Agency. Peng Lihui, Vice President…
Read More » -
Press Release
iCHASE Introduces the World’s First AI-Powered Bird Deterrent With Full Data Tracking at IPPE 2026
ATLANTA, Dec. 15, 2025 /PRNewswire/ — iCHASE, a global leader in AI-driven agricultural biosecurity solutions, will showcase the world’s first…
Read More » -
World Finance names iib West Africa the Best Commercial Bank in Cape Verde for 2025
News provided by World News Media LONDON, Dec. 15, 2025 /PRNewswire/ — iib West Africa has been named the Best…
Read More » -
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor
– The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours…
Read More » -
Press Release
MEDEZE Receives Frost & Sullivan’s 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine
The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia SAN ANTONIO, Dec. 15, 2025…
Read More » -
Business Wire2 weeks ago
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe
ATHENS, Greece–(BUSINESS WIRE)– ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional…
Read More »